153 related articles for article (PubMed ID: 11072785)
21. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article.
Kondziolka D; Kano H; Harrison GL; Yang HC; Liew DN; Niranjan A; Brufsky AM; Flickinger JC; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):792-800. PubMed ID: 20887087
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
25. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
26. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE; Fischer D
Radiat Oncol; 2014 Dec; 9():267. PubMed ID: 25472758
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for patients with microsurgically resected brain metastases.
Korinth MC; Delonge C; Hütter BO; Gilsbach JM
Onkologie; 2002 Oct; 25(5):420-5. PubMed ID: 12415195
[TBL] [Abstract][Full Text] [Related]
28. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
29. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.
Niwińska A; Tacikowska M; Murawska M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1134-9. PubMed ID: 19932944
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.
Castaneda CA; Flores R; Rojas KY; Castillo M; Dolores-Cerna K; Flores C; Belmar-Lopez C; Milla E; Gomez H
CNS Oncol; 2015; 4(3):137-45. PubMed ID: 25906174
[TBL] [Abstract][Full Text] [Related]
33. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Cai G; Yang Z; Cao L; Hu C; Guo X; Sun J; Chen J
Breast Cancer; 2016 Sep; 23(5):732-9. PubMed ID: 26267412
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution.
Fleckenstein K; Hof H; Lohr F; Wenz F; Wannenmacher M
Strahlenther Onkol; 2004 May; 180(5):268-73. PubMed ID: 15127156
[TBL] [Abstract][Full Text] [Related]
36. [Radiotherapy of brain metastases of breast cancer].
Kanazawa H; Morita K; Fuwa N
Gan No Rinsho; 1985 Dec; 31(15):1858-64. PubMed ID: 4094072
[TBL] [Abstract][Full Text] [Related]
37. Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.
Tai CH; Wu CC; Hwang ME; Saraf A; Grubb C; Jani A; Lapa ME; Andrews JIS; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJ
CNS Oncol; 2018 Jan; 7(1):25-34. PubMed ID: 29392968
[TBL] [Abstract][Full Text] [Related]
38. The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis.
Gerdan L; Segedin B; Nagy V; Khoa MT; Trang NT; Schild SE; Rades D
Clin Neurol Neurosurg; 2013 Oct; 115(10):2108-10. PubMed ID: 23954201
[TBL] [Abstract][Full Text] [Related]
39. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.
Lee YK; Park NH; Kim JW; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2008 Mar; 108(3):505-9. PubMed ID: 18191184
[TBL] [Abstract][Full Text] [Related]
40. [Radiation therapy in brain metastases].
Tsuchiya M; Shinozaki J; Hashida I; Kawaguchi T; Yamashita T; Kaneta K
Gan No Rinsho; 1989 Jan; 35(1):9-14. PubMed ID: 2493528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
